Levetiracetam Injection
Product Images NDC 0143-9673

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 0143-9673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Levetiracetam Injection 1)

FDA Label Image

Ndc 0143-9673-25 Levetiracetam Injection 500 mg/5 mL (100 mg/ml) Rx Only Must Be Diluted Prior To Administration For Iv Use Only 25 X 5 mL Single Dose Vials Each 5 mL Vial Contains 500 mg Levetiracetam, 8.2 mg Sodium Acetate Trihydrate, 45 mg Sodium Chloride, Glacial Acetic Acid For Ph Adjustment To 6. Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15ºc To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Levetiracetam Injection 10)

This is a product identification tag that includes a Global Trade Item Number (GTIN), a serial number (SN), an expiration date in Month-Month-Year-Year-Year format (EXP), and a lot number (LOT). This information can be used to track and manage inventory, ensure product quality and traceability, and facilitate product recalls if necessary.*

FDA Label Image

Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 (Levetiracetam Injection 2)

FDA Label Image

Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (Levetiracetam Injection 3)

FDA Label Image

Figure 3: Responder Rate (≥50% Reduction From Baseline) In Study 3 (Levetiracetam Injection 4)

FDA Label Image

Figure 4: Responder Rate (≥ 50% Reduction From Baseline) In Study 4 (Levetiracetam Injection 5)

FDA Label Image

Figure 5: Responder Rate For All Patients Ages 1 Month To < 4 Years (≥ 50% Reduction From Baseline) In Study 5 (Levetiracetam Injection 6)

FDA Label Image

Figure 6: Responder Rate (≥50% Reduction From Baseline) In Pgtc Seizure Frequency Per Week In Study 7 (Levetiracetam Injection 7)

FDA Label Image

Ndc 0143-9673-01 Levetiracetam Injection 500 mg/5 mL (100 mg/ml) Must Be Diluted Prior To Administration For Iv Use Only Rx Only 5 mL Single Dose Vial Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Levetiracetam Injection 8)

This is a medication called Levetiracetam that comes in a single-dose vial. It is meant for intravenous use only and should be diluted before administration. The usual dosage instructions can be found on the package. It should be stored at a temperature between 15°C to 30°C and should be retained in the carton until the time of use. It is distributed by an unidentified company. Lot and expiry information are included.*

FDA Label Image

Ndc 0143-9673-10 Levetiracetam Injection 500 mg/5 mL (100 mg/ml) Rx Only Must Be Diluted Prior To Administration For Iv Use Only 10 X 5 mL Single Dose Vials Each 5 mL Vial Contains 500 mg Levetiracetam, 8.2 mg Sodium Acetate Trihydrate, 45 mg Sodium Chloride, Glacial Acetic Acid For Ph Adjustment To 6. Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15ºc To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Levetiracetam Injection 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.